Medicare Enrolled
Dr. Meghan Borden Trojan, D.O.
Cardiovascular Disease · Pittsburgh, PA
Practice pattern: Electrophysiology & Cardiac
— Practice combining electrophysiology and cardiac services
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Borden Trojan from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Borden Trojan?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Borden Trojan
Dr. Meghan Borden Trojan is a cardiovascular disease specialist in Pittsburgh, PA, with 14 years of NPI registration. Based on federal Medicare data, Dr. Borden Trojan performed 1,692 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Borden Trojan received a total of $4,999 from 34 pharmaceutical and/or device companies across 258 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Borden Trojan is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 14 years of NPI registration
▲ 1,692 Medicare services
$4,999 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗1,692
Medicare services
Bottom 46% in PA for cardiovascular disease
Not available
Unique patients (not deduplicated)
$56
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
400 | $61 | $135 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
296 | $10 | $65 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
287 | $83 | $200 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
144 | $88 | $201 |
| EKG interpretation and report A standard electrocardiogram test that records the heart's electrical activity using at least 12 leads. The service includes a professional interpretation of the results and a written report. |
76 | $5 | $20 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
76 | $126 | $275 |
| Remote pacemaker/defibrillator monitoring, 90 days Remote evaluation of a pacemaker or implantable defibrillator system within 90 days of the last check. |
57 | $14 | $40 |
| Anticoagulant management for warfarin Management of anticoagulant therapy for a patient taking warfarin. This service involves monitoring and adjusting the medication regimen. |
52 | $7 | $20 |
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
52 | $47 | $75 |
| Remote pacemaker monitoring, 90 days Remote assessment of a pacemaker system, including single, dual, multiple lead, or leadless devices, performed up to 90 days apart. |
43 | $21 | $45 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
34 | $224 | $590 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
32 | $113 | $225 |
| Continuous EKG monitoring review, 48-7 days Review and interpretation of continuous external EKG recordings lasting more than 48 hours up to 7 days. |
26 | $18 | $50 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
22 | $46 | $200 |
| Technetium Tc-99m sestamibi diagnostic injection A diagnostic injection of technetium Tc-99m sestamibi used for imaging studies. |
22 | $115 | $147 |
| Continuous external EKG monitoring, 48 hours to 7 days This procedure involves recording the heart's electrical activity continuously using an external device for a period exceeding 48 hours but not more than 7 days. |
20 | $9 | $30 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
17 | $52 | $150 |
| Remote evaluation of implantable defibrillator system Remote assessment of a single, dual, or multiple lead implantable defibrillator system within 90 days of the previous evaluation. |
14 | $18 | $85 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while an electrocardiogram is monitored under physician supervision. |
11 | $15 | $50 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram, with physician review of the results. |
11 | $10 | $175 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
15.2% high complexity
9.0% medium
75.8% routine
Industry Payment Transparency
Open Payments through 2024 ↗$4,999
Total received (2018-2024)
Avg $714/year across 7 years
Top 34% in PA for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
34
Companies
258
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$942
2023
$963
2022
$528
2021
$1,161
2020
$465
2019
$837
2018
$103
Payments by company (2024)
Lexicon Pharmaceuticals, Inc.
$102
Kestra Medical Technology Services, Inc.
$88
Novartis Pharmaceuticals Corporation
$85
Bayer Healthcare Pharmaceuticals Inc.
$82
Boehringer Ingelheim Pharmaceuticals, Inc.
$79
Merck Sharp & Dohme LLC
$78
SCPHARMACEUTICALS INC.
$76
PFIZER INC.
$63
Janssen Pharmaceuticals, Inc
$56
Amgen Inc.
$50
E.R. Squibb & Sons, L.L.C.
$49
Esperion Therapeutics, Inc.
$31
Edwards Lifesciences Corporation
$30
HEARTFLOW, INC.
$23
SANOFI-AVENTIS U.S. LLC
$19
ATRICURE, INC.
$15
AstraZeneca Pharmaceuticals LP
$15
Top 3 companies account for 29.2% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$562
Novartis Pharmaceuticals Corporation
$495
PFIZER INC.
$439
Janssen Pharmaceuticals, Inc
$373
Boehringer Ingelheim Pharmaceuticals, Inc.
$298
E.R. Squibb & Sons, L.L.C.
$254
AstraZeneca Pharmaceuticals LP
$226
CVRx, Inc.
$209
Actelion Pharmaceuticals US, Inc.
$185
Kestra Medical Technology Services, Inc.
$183
Impulse Dynamics (USA) Inc.
$172
Merck Sharp & Dohme LLC
$149
Amarin Pharma Inc.
$147
SANOFI-AVENTIS U.S. LLC
$127
Bayer Healthcare Pharmaceuticals Inc.
$103
Lexicon Pharmaceuticals, Inc.
$102
Merck Sharp & Dohme Corporation
$100
Bayer HealthCare Pharmaceuticals Inc.
$97
SCPHARMACEUTICALS INC.
$93
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$89
Edwards Lifesciences Corporation
$74
Abbott Laboratories
$74
Boston Scientific Corporation
$60
Esperion Therapeutics, Inc.
$51
Relypsa, Inc.
$50
iRhythm Technologies, Inc.
$50
ATRICURE, INC.
$45
Vifor Pharma, Inc.
$42
AtriCure, Inc.
$37
Preventice Services, LLC
$29
HEARTFLOW, INC.
$23
Novo Nordisk Inc
$22
Regeneron Healthcare Solutions, Inc.
$18
Alnylam Pharmaceuticals Inc.
$18
Top 3 companies account for 29.9% of all-time payments
Associated products mentioned in payments ›
ATRICURE ATRICLIP LAA EXCLUSION · Assure WCD · BRILINTA · BYDUREON · Barostim Neo System · CAMZYOS · CARDIOMEMS · CHANTIX · CardioMEMS HF System · Corlanor · ELIQUIS · ENTRESTO · EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX · FARXIGA · FFRct · FUROSCIX · JARDIANCE · Kerendia · LEQVIO · LOKELMA · LUX-Dx Insertable Cardiac Monitor · LifeVest · MULTAQ · NEXLETOL · ONPATTRO · OPSUMIT · OPSUMIT MACITENTAN · OPTIMIZER · Ozempic · PRADAXA · PRALUENT · Repatha · UPTRAVI · VERQUVO · VYNDAQEL · Vascepa · Veltassa · WATCHMAN FLX · XARELTO · ZIO Patch · ZIO XT Patch
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Cardiologists in nearby ZIP areas
196
County median income
$76,393
Nearest hospital to ZIP centroid (approximate)
WEST PENN HOSPITAL
1.8 mi
1.8 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Borden Trojan is an electrophysiology & cardiac specialist, with moderate Medicare volume.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Borden Trojan experienced with hospital follow-up visit, moderate complexity?
Based on Medicare claims data, Dr. Borden Trojan performed 400 hospital follow-up visit, moderate complexity services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Borden Trojan receive payments from pharmaceutical companies?
Yes. Dr. Borden Trojan received a total of $4,999 from 34 companies across 258 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Borden Trojan's costs compare to other cardiologists in Pittsburgh?
Dr. Borden Trojan's average Medicare payment per service is $56. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Borden Trojan) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in Pittsburgh
Browse cardiologists in Pittsburgh ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in PA
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in PA
Which PA cardiologists receive the most from drug and device companies.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology